ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232,549 | -18.9% | 42,785 | +0.0% | 0.00% | – |
| Q2 2023 | $286,831 | -23.9% | 42,778 | -0.0% | 0.00% | – |
| Q1 2023 | $376,698 | +165.3% | 42,780 | +129.8% | 0.00% | – |
| Q4 2022 | $141,982 | +6.6% | 18,619 | -50.0% | 0.00% | – |
| Q3 2022 | $133,133 | -11.8% | 37,236 | +99.7% | 0.00% | – |
| Q2 2022 | $151,000 | -41.5% | 18,647 | +0.2% | 0.00% | – |
| Q1 2022 | $258,000 | -51.5% | 18,610 | -1.9% | 0.00% | – |
| Q4 2021 | $532,000 | +53.3% | 18,978 | +85.6% | 0.00% | – |
| Q3 2021 | $347,000 | -17.2% | 10,223 | +44.2% | 0.00% | – |
| Q4 2020 | $419,000 | -96.5% | 7,089 | -97.2% | 0.00% | -100.0% |
| Q2 2019 | $12,020,000 | – | 248,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |